Home › Idiopathic Thrombocytopenic Purpura › North Carolina › Durham
Idiopathic Thrombocytopenic Purpura clinical trials in Durham, NC
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Duke University Hospital, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Duke University Hospital, Durham
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingPhase 1
- Universtity of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
RecruitingPhase 3
- Duke University Medical Center, Durham
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Greenville, NC6 studies
- Washington, DC6 studies
- Boston, MA6 studies
- The Bronx, NY5 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Portland, OR4 studies
- Houston, TX4 studies
- Cedar Rapids, IA3 studies
- New Orleans, LA3 studies
- Cleveland, OH3 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.